In cancer patients, CD4 T cells recognize unmutated self-tumor antigens, viral antigens causative of tumor transformation, and mutant peptides (neoantigens) resulting from non-synonymous mutations or gene fusion in the cancer genome [22]. This evidence concerns the gene CD4 and cancer.